Detalles de la búsqueda
1.
Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease.
Am J Gastroenterol
; 119(2): 306-312, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737675
2.
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease.
Gastrointest Endosc
; 2024 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462057
3.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 69(6): 2165-2174, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594435
4.
Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks.
J Infect Dis
; 228(4): 391-401, 2023 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36735342
5.
Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: A role for IL-17A.
Int J Cancer
; 152(12): 2607-2614, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36346104
6.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Clin Gastroenterol Hepatol
; 21(1): 182-191.e2, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644343
7.
Next-generation sequencing mutation analysis on biliary brush cytology for differentiation of benign and malignant strictures in primary sclerosing cholangitis.
Gastrointest Endosc
; 97(3): 456-465.e6, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36252869
8.
Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia: a Delphi study.
Gastrointest Endosc
; 97(4): 767-779.e6, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36509111
9.
Disease burden in primary sclerosing cholangitis in the Netherlands: A long-term follow-up study.
Liver Int
; 43(3): 639-648, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328957
10.
Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease.
Scand J Gastroenterol
; 58(9): 980-987, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36970968
11.
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis.
J Pathol
; 258(3): 227-235, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35897137
12.
Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn's disease are not incorporated in routine care.
Int J Colorectal Dis
; 38(1): 254, 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855846
13.
Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
Clin Gastroenterol Hepatol
; 2022 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572110
14.
Risk Prediction and Comparative Efficacy of Anti-TNF vs Thiopurines, for Preventing Postoperative Recurrence in Crohn's Disease: A Pooled Analysis of 6 Trials.
Clin Gastroenterol Hepatol
; 20(12): 2741-2752.e6, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34687970
15.
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies.
Clin Gastroenterol Hepatol
; 20(8): 1671-1686.e16, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33933376
16.
Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 67(7): 2849-2856, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181168
17.
Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease: A Nationwide Cohort Study.
Ann Surg
; 273(3): 557-563, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31188225
18.
No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis.
Clin Gastroenterol Hepatol
; 18(8): 1777-1784.e2, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31610337
19.
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(1): 179-187.e6, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31100458
20.
Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice.
J Gastroenterol Hepatol
; 35(11): 1893-1901, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32291796